Subsequent MRI again showed subtle changes. The T1 and T2 weighted images were unremarkable apart from nonvisualization of the septum pellucidum giving an appearance similar to a cavum septum pellucidum (Fig 2 a and 3 ), but careful evaluation of the fluid attenuation inversion recovery (FLAIR) images revealed a septum pellucidum mass having a minimal signal change from the cerebrospinal fluid (CSF) (Fig   4) . It showed a very high signal on T2 and very low signal on T1 weighted images making it difficult to appreciate on these sequences. This mass was diffusely involving the septum pellucidum, and extending to merge with the medial wall and the roof of the left lateral ventricle. Some irregularity was noted in the uppermost ventricular sections at the sites of tumor involvement (Fig 5) . The mass was measuring 3x2.5x1.5 cm size in the region of the septum pellucidum, and ranging from 0.8-1.2 cm thickness in the lateral ventricular wall. No significant enhancement was seen in the postcontrast images (Fig 2) and no restriction in the diffusion was detected (Fig 6) .
Taken these findings, in a 28 years old patient, the diagnosis of a non-enhancing intraventricular neoplasm involving the septum pellucidum was made; with the differential diagnosis included ependymoma, subependymoma, low grade glioma and central neurocytoma.
The patient underwent right frontal craniotomy and gross total resection of the mass, with third ventriculostomy.
The histopathological examination demonstrated characteristic features of subependymoma including monomorphic cells with pseudorosettes formation around the blood vessels in a background of marked edema and hemorrhage. There was no evidence of necrosis or pleomorphism (fig 7 and 8) . The tumor cells also showed positivity for glial fibrillary acidic protein (GFAP) and MIB-1 proliferation index was lower than 1%.
The patient tolerated the surgery well without significant postoperative complications. She was followed up by neurosurgery service for the last one and a half year and she is doing well with no evidence of recurrence in the follow up CT and MRI studies (Fig 9 and 10 ). Subependymoma is a rare, benign, slowly growing tumor with non-invasive characteristics, it accounts for less than 1% of all intracranial neoplasms [1, 2] . It was first described by Scheinker in 1945 which was followed by slightly more than hundred case reports and few studies that evaluated the imaging features and the treatment options [3] . These potentially curable tumors arise from the walls of the lateral or fourth ventricles, so the differentiation from other intraventricular tumors especially ependymomas has a therapeutic importance. However; due to its rarity and variable imaging characteristics, reliable pre-operative diagnosis remains challenging.
Most of these tumors are asymptomatic, but when symptomatic, subependymomas often present with symptoms related to CSF obstruction and hydrocephalus [1, 4] . The commonest locations are the fourth and lateral ventricles, but have also been reported in the third ventricle, septum pellucidum, and the spinal canal [2] [3] [4] [5] [6] .
The world health organization (WHO) classifies subependymoma as a grade 1 neoplasm [2] , yet the histological origin has remained controversial. In the 1970s, electron microscopy of subependymoma demonstrated a mixed population of ependymal cells, astrocytes, and intermediate morphology bi-potential cells with the capability of differentiating into ependymal cells or astrocytes [1, 7, 8] . Subependymomas are characterized by an extremely low mean MIB-1 labeling index, an important and well-recognized marker of cell proliferation, which raise the possibility that this lesion more likely be a hamartoma rather than a neoplasm [7, 9, 10] .
Histopathologically, subependymomas show low cellularity; and characterized by clusters of isomorphic tumor cell nuclei embedded in a dense fibrillary matrix of glial cell processes with frequent microcysts and absent mitoses. The cells are frequently showing rosette appearance around the blood vessels. These neoplasms are strongly immunoreactive for GFAP [1, 6, 10] .
Clinical presentation:
Most of these tumors are asymptomatic and detected incidentally at autopsy. Subependymomas sometimes obstruct critical portions of the CSF pathway, causing hydrocephalus. The most common symptoms include headache, gait ataxia, vertigo or dizziness, nausea and vomiting [1, 5] .
Most of subependymomas are smaller than 2 cm in size, however; symptomatic tumors are usually larger. The presence of symptoms was found by some authors to be related to the tumor size, with the majority of symptomatic subependymomas measuring greater than 3-5 cm [1, 4, 5] . Maiuri concluded that most important factor related to the presenting symptom is the tumor location; with tumors originating in the region of foramen of monro and third ventricle appear smaller in size at presentation than those not interfering with the CSF flow like in the trigone of the ventricle [4, 9] . In our case, the patient presented with headache and vomiting which are frequent presenting symptoms, in addition to reduced vision. Ophthalmological examination revealed papilledema likely related to the increased CSF pressure caused by tumor obstructing its pathway that explained the patient symptoms.
These neoplasms may become symptomatic at any age and develop in both sexes, but exhibit a peak incidence in middle-aged and elderly male patients [6, 10] .
Imaging:
Unlike the current case, most of the literature described well-defined, lobulated subependymomas which are easily detected by CT and MR imaging. Authors also reported nonspecific and variable imaging characteristics of these neoplasms with the imaging features found to be related to the anatomical location.
Common features of subependymoma include a lobulated, well-defined intraventricular mass with no paraventricular extension and no peritumoral edema. The majority are solid or solid with areas of cystic degeneration [1, [11] [12] [13] .
On CT, the majority of subependymomas appear as intraventricular masses that are hypodense or isodense. On MRI, these tumors are usually well-defined solid with a hypo to isointense signal on T1 weighted images and a hyperintense signal on T2 weighted images.
Here, we described a case of subependymoma which demonstrated very subtle and unusual imaging appearance. Unlike others, the current case showed no well-defined lobulated intraventricular mass, but a rather diffuse infiltration of the septum pellucidum and the ventricular wall. The mass had a very low attenuation on CT, and a homogenous very high signal on T2 and low signal on T1 weighted MRI, which rendered that lesion inseparable from the surrounding CSF. No evidence of hemorrhage, cyst or contrast enhancement was noted in the current case.
Studies showed variable CT and MRI enhancement characteristics of these tumors, ranging from absent to intense DISCUSSION enhancement. Heterogeneous contrast enhancement and calcification are recognized features of the fourth ventricular subependymomas, while lateral ventricular subependymomas usually lack calcification and show minimal or no contrast enhancement [1, 11, 12, 14] .
Differential diagnosis:
As these tumors are rare with non-specific imaging characteristics, the differentiation from other intraventricular lesions can be very difficult. The differential diagnosis includes ependymoma, central neurocytoma, subependymal giant cell astrocytoma, choroid plexus papilloma, meningioma, glioma and metastasis. The age, location and the imaging features help in narrowing the differential diagnosis [12] .
The lateral ventricular subependymoma is more easily differentiated from other intraventricular tumors comparing to the fourth ventricular subependymoma. Jelinek concluded that the lateral ventricular tumors are always enhancing and the only non-enhancing tumor is subependymoma [4, 13] .
According to Hoeffel, even though there is no specific sign of subependymoma, it should be considered if we are encountering a complete intraventricular mass causing little or no edema, which is non-enhancing or minimally enhancing [12] . Furthermore; the slow progression of these tumors helps in the differentiation from other more common tumors of the ventricles.
Supratentorial ependymomas are often paraventricular while subependymomas are entirely intraventricular. Ependymomas are more likely to show calcification, cyst formation and contrast enhancement than supratentorial subependymoma [1, 12, 14] .
Unlike subependymoma, the choroid plexus papilloma occurs in young children in the region of the choroid plexus and it intensely enhances. The subependymal giant cell astrocytomas are always located near the foramen of monro and intensely enhance. They are associated with ventricular wall calcifications as part of the stigmata of tuberous sclerosis which help in their differentiation.
Central neurocytoma is a tumor which is related to the septum pellucidum. Both subependymoma and central neurocytoma tend to occur in the anterior portions of the lateral ventricles, but central neurocytoma is usually seen in a younger age group and shows a more heterogeneous isointense signal on T1, T2 MRI. Cysts, calcification and contrast enhancement are common features of central neurocytoma but they are rare in subependymoma. Furthermore; subependymomas almost always appear hyperintense on T2 images.
Meningiomas are usually seen in middle age patients especially females, they are frequently calcified and intensely enhance, with iso-or hyperdense attenuation on CT in contrast to subependymomas which appear iso or hypodense. On MRI, meningiomas demonstrate iso to hyperintense signal on T2 and iso to hypo intense signal on T1 weighted images unlike subependymomas which appear hyperintense on T2. Meningioma resembles subependymoma in being homogenous on both CT and MRI.
Gliomas are differentiated by their fast growth as well as the heterogeneous appearance and involvement of the corpus callosum [1, 4, 12] .
In the 4th ventricle the differentiation between subependymomas and other intraventricular tumors especially ependymomas is more difficult because the 4th ventricular subependymomas can show calcification and heterogeneous enhancement. Unlike subependymomas, ependymomas may infiltrate into the adjacent paraventricular parenchyma, an important finding to differentiate these two tumors [4] .
Treatment and prognosis:
The optimal therapy for symptomatic subependymomas is complete surgical excision which was found to be curative. The preoperative diagnosis is helpful as these lesions are benign slowly growing and has better prognosis than other common intraventricular tumors, which help in the preoperative planning. Lateral ventricular subependymomas often can be completely resected, while the 4th ventricular tumors are frequently arising from the floor of the ventricle adjacent to the brainstem and the cranial nerves rendering complete resection difficult.
In cases in which surgery is risky, in certain tumor locations, the decision may be to follow up these tumors. If the patient is symptomatic, subtotal resection and debulking may be performed to improve the CSF pathway, as the outcome is favorable even if removal is subtotal. Follow up MRI is advised after partial resection [1, 13, 15] .
The current surgical approach of these tumors like other intraventricular tumors depends on the exact location of the lesion, the amount of hydrocephalus and the experience of the surgeon. Interhemispheric transcallosal approach is preferred over transcortical approach to reduce damage of the neural tissues [7, 16] . In our patient, this was not possible due to prominent vascularity in the interhemispheric area, so transcortical approach was decided to remove this septum pellucidum tumor. In spite of tumor extension to the left ventricular wall, right frontal craniotomy was performed in order to avoid the dominant hemisphere particularly the speech area.
If we are dealing with a small tumor, neuronavigation and the use of microneurosurgical techniques can be useful to guide the surgeon and minimize neural damage.
Prognosis of the resected tumors is generally excellent. Few studies reported a worse prognosis in the older age group, most likely related to the higher incidence of age-related surgical complications. Recurrence is very rare after complete tumor resection.
The role of radiotherapy in the treatment of these lesions is still controversial due to the limited number of studies; it is not generally recommended if the resection is complete, but can be considered after subtotal resection or recurrent tumors [11, 16] . Subependymoma is a rare low grade curable tumor. While the appearance is nonspecific, this neoplasm should be considered in the differential diagnosis of a non-enhancing entirely intraventricular lesion, which is showing no edema, especially if this lesion appears homogenous. We present a case of this rare tumor with unusually subtle imaging appearance simulating a cavum septum pellucidum, to draw attention to the difficulty in appreciating some intracranial tumors and the importance of systematically approaching the different regions in the brain, especially the ventricles. 
Incidence
Less than 1% of the intracranial neoplasms Age Most common in middle age, but can occur at any age, most are asymptomatic and discovered at autopsy Gender Male to female ratio is about 3:1 Etiology
Mixed ependymal and glial cells origin
Risk factors
No known risk factors
Imaging appearance
Completely intraventricular mass, usually homogeneously hypo to isodense on CT, hypointense on T1 and hyperintense on T2 MRI, usually showing minimal or no enhancement.
Treatment
Optimal therapy is complete surgical resection, if not possible, debulking or partial resection Prognosis Generally favorable, complete resection is curable 
